Biomarin Pharmaceutical Inc (BMRN)

Return on assets (ROA)

Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Net income (ttm) US$ in thousands 520,417 657,241 523,883 426,859 322,291 256,589 205,455 167,645 147,021 99,991 71,615 141,561 83,912 54,070 39,347 -64,080 15,917 837,214 795,090 859,100
Total assets US$ in thousands 7,614,870 7,456,340 7,147,010 6,988,940 6,851,200 7,067,120 6,872,670 6,841,600 6,758,160 6,563,170 6,433,700 6,375,070 6,264,040 6,145,840 6,062,710 6,003,320 5,977,480 5,898,500 5,805,050 5,848,020
ROA 6.83% 8.81% 7.33% 6.11% 4.70% 3.63% 2.99% 2.45% 2.18% 1.52% 1.11% 2.22% 1.34% 0.88% 0.65% -1.07% 0.27% 14.19% 13.70% 14.69%

September 30, 2025 calculation

ROA = Net income (ttm) ÷ Total assets
= $520,417K ÷ $7,614,870K
= 6.83%


Peer comparison

Sep 30, 2025

Company name
Symbol
ROA
Biomarin Pharmaceutical Inc
BMRN
6.83%
Arrowhead Pharmaceuticals Inc
ARWR
-0.12%
Regeneron Pharmaceuticals Inc
REGN
11.40%